FDA Research Opportunity - Immune Responses to Influenza, Respiratory Syncytia Virus and Adjuvanted Vaccines
To submit your application, scroll to the bottom of this opportunity and click APPLY.
A complete application consists of:
- An application
- Transcripts – Click here for detailed information about acceptable transcripts
- A current resume/CV, including academic history, employment history, relevant experiences, and publication list
- One educational or professional recommendation
All documents must be in English or include an official English translation.
If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity in your email.
*Applications will be reviewed on a rolling-basis.
FDA Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in White Oak, Maryland
The Center for Biologics Evaluation and Research (CBER) is one Center within the Food and Drug Administration, an Agency within the United States Government's Department of Health and Human Services. CBER's mission is to protect and enhance the public health through the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies.
Research Project: You will be joining a training opportunity to study humoral immune responses following, RSV or influenza infections and vaccination in humans as well as novel vaccine adjuvants and mucosal vaccines.
Learning Objectives: Under the guidance of a mentor, you will be trained in advanced techniques developed in the lab including virus neutralization assays, cytokine production; whole genome gene-fragment phage display libraries (GFPDL); Surface Plasmon Resonance (SPR); recombinant protein expression in bacterial and mammalian systems. This opportunity will train you on mode of action and safety of novel adjuvants used to enhance immune responses to multiple vaccines using human derived cells and organoids such as monocytes/macrophages, bronchio-epithelial and nasal-epithelial cells grown under Air-Liquid-Interphase (ALI).
Mentor: The mentor for this opportunity is Hana Golding (hana.golding@fda.hhs.gov). If you have questions about the nature of the research, please contact the mentor.
Anticipated Appointment Start Date: August 31, 2026. Start date is flexible and will depend on a variety of factors.
Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.
Level of Participation: The appointment is full time.
Participant Stipend: The participant will receive a monthly stipend commensurate with educational level and experience.
Citizenship Requirements: This opportunity is available to U.S. citizens only and Legal Permanent Residents (LPRs).
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
The qualified candidate should have received a bachelor's, master's, or doctoral degree in one of the relevant fields. Degree must have been received within the past three years.
Preferred skills
- Experience in scientific research in a laboratory setting.
I am a U.S. citizen; or I have lived in the United States for at least 36 out of the past 60 months. (36 months do not have to be consecutive.)
ORISE GO
The ORISE GO mobile app helps you stay engaged, connected and informed during your ORISE experience – from application, to offer, through your appointment and even as an ORISE alum!
